[News] KBIOHealth–KRON–Young Science Sign Tri-party MOU to Establish Advanced Equipment

영사이언스
2026-01-21

KBIOHealth Signs Three-Party Agreement to Build LNP Formulation Equipment for Nucleic Acid Therapeutics


Introduction of Core Process Equipment for LNP (Lipid Nanoparticle) Formulation

 

The Osong Medical Innovation Foundation (KBIOHealth) has signed a three-party Memorandum of Understanding (MOU) with KRON Co., Ltd. and YoungScience Co., Ltd. to establish core process equipment for the formulation of LNP (lipid nanoparticle)-based nucleic acid therapeutics.

Through this agreement, KBIOHealth plans to introduce state-of-the-art formulation equipment and aims to establish a related technical service system within the first half of this year.

In accordance with GMP standards, KBIOHealth will strengthen process reliability and validation capabilities by conducting step-by-step process verification and collaborating closely with client companies.

The newly introduced equipment will be utilized to support technology validation, process scale-up, and commercialization for domestic nucleic acid therapeutic companies. It is expected to provide substantial assistance to companies facing challenges in securing formulation and process expertise.

Looking ahead, KBIOHealth plans to expand its support to include raw material production for nucleic acid therapeutics, contributing to the enhancement of national bio-industry competitiveness through a customized process platform.

 

 

🔗 Read the full article
Source: Dong-A Ilbo